Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by WatchLearnEarnon Oct 11, 2018 2:45am
141 Views
Post# 28778816

RE:RE:RE:Hmm something's brewing

RE:RE:RE:Hmm something's brewingThere has been some discussion along those lines over the past few days and I think you're definitely onto something. With all the positive news about our human trials over the past months, I cannot and will not believe for even a second that they closed the PP due to lack of interest. That's absolutely preposterous. JV or even M&A talks are the logical reason they closed it early in my opinion.

SizzlinSteaks wrote: I haven't been on this board for a while for good reason, and not sure of the previous discussions, however, people here must have questioned why the original PP amount was for "up to $10 million", yet they closed it with just over $1 million. That is a far cry from $10 million and hardly enough raised to take them through phase 2. Makes me wonder if one of the big pharma is finally ready to anti up for a piece of the action here. If so, hold on to your booties. I sure hope so... proper valuation is LONG overdue here. Regardless, I'm in for the long haul.

Cheers!

O12009 wrote:
LAZERR00 wrote:
I know they had a news release but usually those are good for next to nothing, this seems different

With the events Theralase has been attending that allowed many experts in the field to see what they had to offer, the news is starting to get out and more than the small group of investors who haunt this board are starting to invest. The Stock price is going to reflect more and more on the progress being made. The secret is slowly getting out. When the new PR and IR are hired it will increase the pace. Thousands of Canadians are going to become cancer free.

ps 

and rich
glta


 




Bullboard Posts